eXoZymes (EXOZ) vs MiNK Therapeutics (INKT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
MiNK Therapeutics (INKT) has outperformed eXoZymes (EXOZ) over the past year, losing 23.4% versus a loss of 59.0%. MiNK Therapeutics is the larger company by market cap ($57.3 million vs $52.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EXOZ | INKT |
|---|---|---|
| Share price | $5.60 | $11.22 |
| Market cap | $52.06M | $57.26M |
| 1-day change | +0.99% | -1.75% |
| YTD return | -49.17% | +2.42% |
| 1-year return | -58.96% | -23.36% |
| 5-year return | — | -90.48% |
| EPS (TTM) | $-1.19 | $-2.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.40 | $16.93 |
| 52-week low | $4.35 | $8.48 |
| Distance from 52-week high | -69.59% | -33.72% |
| Average volume | 6.80K | 14.20K |
| Shares outstanding | 9.30M | 5.10M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INKT has outperformed EXOZ by 35.6 percentage points over the past year.
EXOZ vs INKT FAQ
Which is bigger, eXoZymes or MiNK Therapeutics?
MiNK Therapeutics (INKT) is larger, with a market capitalization of $57.26M compared with $52.06M for eXoZymes (EXOZ).
Which stock has performed better over the past year, EXOZ or INKT?
INKT returned -23.36% over the past 12 months, compared with -58.96% for EXOZ (price return, excluding dividends). Past performance does not predict future results.
Are eXoZymes and MiNK Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.